2001
DOI: 10.1006/exer.2000.0957
|View full text |Cite
|
Sign up to set email alerts
|

Interphotoreceptor Retinoid Binding Protein Peptide-induced Uveitis in B10.RIII Mice: Characterization of Disease Parameters and Immunomodulation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
31
1
1

Year Published

2004
2004
2015
2015

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 26 publications
(33 citation statements)
references
References 25 publications
0
31
1
1
Order By: Relevance
“…sTNFr-Ig suppresses EAU in rats (8), mice (30), and in humans (10). In these experiments, sTNFr-Ig was added to TNFRp55 Ϫ/Ϫ and WT BM-M 1 h before cytokine stimulation.…”
Section: Ifn-␥-induced Nitrite Production Requires a Signal Through Tmentioning
confidence: 99%
“…sTNFr-Ig suppresses EAU in rats (8), mice (30), and in humans (10). In these experiments, sTNFr-Ig was added to TNFRp55 Ϫ/Ϫ and WT BM-M 1 h before cytokine stimulation.…”
Section: Ifn-␥-induced Nitrite Production Requires a Signal Through Tmentioning
confidence: 99%
“…Male B10.RIII (7INS) mice (5-7 wk old; Harlan Olac) were injected s.c. with 25 g of human interphotoreceptor retinoid binding protein (IRBP) 161-180 peptide emulsified in IFA supplemented with 60 g/ml Mycobacterium (29). Eyes were scored daily for clinical signs of EAU (Table I).…”
Section: Induction and Assessment Of Eaumentioning
confidence: 99%
“…Alternatively, following a loading dose of 100 mg/kg lovastatin, a further group of animals was given twice daily injections of 20 mg/kg lovastatin. Vehicle or lovastatin was first administered on day 5 postimmunization, and then daily until day 12 when maximal cellular infiltration and structural damage has been reported to occur (29). In two separate groups of animals, parenteral lovastatin treatment (20 mg/kg) was supplemented with a daily injection of squalene (2 mg/kg) or a twice-daily injection of mevalanolactone (2 mg/kg).…”
Section: Treatment Of Eaumentioning
confidence: 99%
“…To determine whether autoreactive CD8 T cells were induced by the uveitogenic peptide IRBP161-180 (Silver et al, 1995,Hankey et al, 2001; (Shao et al, 2005b) in the EAUsusceptible B10RIII mouse, we immunized B10RIII mice with IRBP161-180, then, at 13 days post-immunization (p.i. ), prepared T cells from the pooled draining lymph nodes and spleens using nylon wool.…”
Section: Detection Of Cd8 ± Irbp161-180-specific T Cells In the Immunmentioning
confidence: 99%
“…However, we have recently demonstrated that, in both the Lewis rat (Shao et al, 2004) and B6 mouse (Shao et al, 2005a); (Peng et al, 2007), many CD8 autoreactive T cells are activated and actively participate in disease pathogenesis. To determine whether this observation applies to other EAU models, we tested the B10RIII mouse, which is the mouse strain most susceptible to EAU (Hankey et al, 2001,Karabekian et al, 2005. Since our previous studies demonstrated that CD4 and CD8 IRBP-specific T cells in the B6 mouse both responded to the same antigenic epitope (Shao et al, 2005a), we were also interested in testing whether this was also true in the B10RIII mouse.…”
Section: Introductionmentioning
confidence: 99%